retatrutide weight loss efficacy safety trial results First phase 3 data, a Triumph of Science! Weight-loss medicine continues to evolve. – Retatrutide Helped Adults With Diabetes

Major players such as Novo Nordisk and Eli Lilly have concentrated their marketing and clinical efforts in North America, and high healthcare spending levels ensure a broad customer base

Like many chronic diseases, obesity has a wide range of causes and drivers, including those related to genetics, sociocultural factors, mental health, ultra-processed foods, economics, commercial determinants, and environmental factors

A small number of mechanistic studies have explored the cognitive effects of GLP-1 analogues in other populations, such as individuals with type 2 diabetes or obesity

Grapefruit has a natural ability to block an enzyme called CYP3A4, which is important to the absorption of medications

da Silva, Implications of GLP-1 agonist use on airway management, Am